Specify a stock or a cryptocurrency in the search bar to get a summary
Pila Pharma AB
PILAPILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2b clinical trials for type 2 diabetes. The company was incorporated in 2014 and is based in Malmö, Sweden. Address: Norra Vallgatan 72, Malmö, Sweden, 211 22
Analytics
WallStreet Target Price
78.53 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PILA
Dividend Analytics PILA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PILA
Stock Valuation PILA
Financials PILA
Results | 2019 | Dynamics |